AFFX

Affymetrix, Inc. News Headlines

$11.04
*  
0.22
1.95%
Get AFFX Alerts
*Delayed - data as of Jan. 30, 2015  -  Find a broker to begin trading AFFX now
Exchange: NASDAQ
Industry: Capital Goods
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Hospira's Dyloject Cleared in the U.S. for Pain Management - Analyst Blog
12/31/2014 3:45:00 AM - Investopedia


Cyberonics: VNS Therapy Strong, Reimbursement Woes Stay - Analyst Blog
12/30/2014 2:30:00 PM - Investopedia


Cyberonics: VNS Therapy Strong, Reimbursement Woes Stay - Analyst Blog
12/30/2014 2:30:00 PM - Zacks.com


Qiagen Poised on Molecular Diagnostics, International Strength - Analyst Blog
12/30/2014 2:20:00 PM - Investopedia


Qiagen Poised on Molecular Diagnostics, International Strength - Analyst Blog
12/30/2014 2:20:00 PM - Zacks.com


Fluidigm's Single-Cell Workflow to Advance Cancer Research - Analyst Blog
12/30/2014 10:50:00 AM - Investopedia


Fluidigm's Single-Cell Workflow to Advance Cancer Research - Analyst Blog
12/30/2014 10:50:00 AM - Investopedia


Fluidigm's Single-Cell Workflow to Advance Cancer Research - Analyst Blog
12/30/2014 10:50:00 AM - Zacks.com


Can-Fite Enrols First Patient for a Liver Cancer Study - Analyst Blog
12/29/2014 5:10:00 PM - Zacks.com


Affymetrix (AFFX) Touches 52-Week High on Bullish Trends - Analyst Blog
12/29/2014 9:02:00 AM - Investopedia


Affymetrix (AFFX) Touches 52-Week High on Bullish Trends - Analyst Blog
12/29/2014 9:02:00 AM - Zacks.com


Can-Fite Enrols First Patient for a Liver Cancer Study - Analyst Blog
12/29/2014 5:10:00 AM - Investopedia


Cytokinetics Rises After Extending Astellas Agreement - Analyst Blog
12/24/2014 5:10:00 PM - Zacks.com


Myriad Genetics' Ovarian Cancer Test Wins FDA Approval - Analyst Blog
12/24/2014 2:10:00 PM - Investopedia


Myriad Genetics' Ovarian Cancer Test Wins FDA Approval - Analyst Blog
12/24/2014 2:10:00 PM - Zacks.com


Cytokinetics, Incorporated (CYTK) Rises: Stock Jumps 12.6% - Tale of the Tape
12/24/2014 9:32:00 AM - Zacks.com


OncoMed Pharmaceuticals (OMED) Crumbles: Stock Falls by 5.6% - Tale of the Tape
12/24/2014 8:54:00 AM - Zacks.com


Cytokinetics Rises After Extending Astellas Agreement - Analyst Blog
12/24/2014 5:10:00 AM - Investopedia


Stryker & Osiris Team Up to Market Viable Bone Matrix - Analyst Blog
12/23/2014 3:50:00 PM - Zacks.com


Will myRisk Cancer Test Work Wonders for Myriad Genetics? - Analyst Blog
12/23/2014 2:30:00 PM - Investopedia


Will myRisk Cancer Test Work Wonders for Myriad Genetics? - Analyst Blog
12/23/2014 2:30:00 PM - Zacks.com


Walgreens Beats Q1 Earnings, Alliance Boots Deal Bears Fruit - Analyst Blog
12/23/2014 2:02:00 PM - Investopedia


Walgreens Beats Q1 Earnings, Alliance Boots Deal Bears Fruit - Analyst Blog
12/23/2014 2:02:00 PM - Zacks.com


ADMA Biologics (ADMA) Jumps: Stock Rises 7% - Tale of the Tape
12/23/2014 9:11:00 AM - Zacks.com


Gilead Sciences Slumps: GILD Tumbles 14.3% in Session - Tale of the Tape
12/23/2014 8:46:00 AM - Zacks.com